 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- ||| Y150 / YZY Biopharma
New P1 trial: A Phase I Clinical Trial of Y150 in the Treatment of Relapsed or Refractory Multiple Myeloma (clinicaltrials.gov) - Aug 17, 2021
P1, N=75, Recruiting, Sponsor: Wuhan YZY Biopharma Co., Ltd.